Can pregabalin cause constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pregabalin Can Cause Constipation

Yes, pregabalin does cause constipation as a recognized adverse effect, though it occurs less frequently than other common side effects like dizziness and somnolence.

Evidence from FDA Drug Labeling

The FDA-approved prescribing information for pregabalin explicitly lists constipation as an adverse reaction across multiple indications 1. In controlled trials:

  • Partial-onset seizures (adults): Constipation occurred in 4% of pregabalin patients vs. 2% on placebo, with dose-related incidence of 1% (150 mg/day), 1% (300 mg/day), and 7% (600 mg/day) 1
  • Neuropathic pain associated with spinal cord injury: Constipation occurred in 8.2% of pregabalin patients vs. 5.7% on placebo 1

Importantly, the FDA label includes postmarketing reports of serious gastrointestinal complications: "events related to reduced lower gastrointestinal tract function (e.g., intestinal obstruction, paralytic ileus, constipation) when pregabalin was co-administered with medications that have the potential to produce constipation, such as opioid analgesics" 1.

Clinical Context from Guidelines

Multiple clinical practice guidelines acknowledge constipation as a pregabalin side effect:

  • The 2017 neuropathic corneal pain guideline lists "constipation" among common side effects of gabapentinoids (gabapentin and pregabalin) 2
  • The 2022 gastroparesis management guideline notes that pregabalin can cause "constipation" as a side effect when used for neuropathic pain 3
  • The 2011 painful diabetic neuropathy consensus identifies "constipation" among the most frequent side effects of pregabalin 4

Research Evidence

A comprehensive 2015 pooled analysis of 31 randomized trials (7,510 patients, 805 patient-years of pregabalin exposure) identified constipation with a risk difference of 2.3% (95% CI: 1.5-3.2%) compared to placebo 5. This analysis established constipation as one of nine adverse events with clinically meaningful increased risk.

Recent case reports further document this effect:

  • A 2023 case report described a 76-year-old woman who developed constipation (along with balance disorder, asthenia, and edema) on pregabalin 300 mg daily, with symptoms improving upon dose reduction 6
  • A 2026 post-bunionectomy pain trial noted "mild constipation" as more common in pregabalin groups 7

Clinical Implications

Constipation from pregabalin is:

  • Dose-related: Higher doses (600 mg/day) show 7% incidence vs. 1% at lower doses 1
  • Less common than neurological side effects: Dizziness (17% risk difference) and somnolence (10.8% risk difference) are far more frequent 5
  • Potentially serious when combined with opioids: The FDA specifically warns about reduced GI motility complications when pregabalin is co-prescribed with constipating medications 1

Management approach:

  • Anticipate constipation prophylactically in patients on higher pregabalin doses (≥600 mg/day)
  • Exercise particular caution when combining pregabalin with opioids or other constipating medications
  • Consider dose reduction if constipation becomes problematic, as demonstrated in the case report where reducing from 300 mg to 150 mg daily resolved symptoms 6
  • Monitor elderly patients more closely, as they may be more susceptible to dose-related adverse effects 6

Related Questions

What is the appropriate treatment for constipation in a patient taking pregabalin?
Can periorbital edema occur as an adverse effect of pregabalin in a puppy, and how should it be managed?
How should I approach a 57-year-old female presenting with a one-day fever, recent bereavement-related insomnia, known restless‑leg syndrome treated with pregabalin 150 mg, and unexplained thrombocytopenia, with vitals SpO₂ 98%, pulse 84 bpm, temperature 37.5 °C, blood pressure 110/70 mmHg?
Can Lyrica (pregabalin) be used to treat involuntary movements?
Can a person on Vivitrol (naltrexone) benefit from pregablin (Lyrica)?
What are the differential diagnoses for a 48-year-old woman with a 20-year history of chronic low back pain, 2–3 years of intermittent left-sided sciatica, and a few months of intermittent bilateral lower extremity tightness, aching, and discomfort associated with elevated C-reactive protein (CRP)?
How should I evaluate and manage a patient with a three‑month history of persistent bitter dysgeusia (bitterness in the mouth and tongue)?
What are the normal erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels for a 48-year-old woman?
How should hyperkalemia be treated, especially when serum potassium is ≥6.5 mmol/L or ECG changes are present?
What is the appropriate treatment for constipation in a patient taking pregabalin?
Can metformin be safely continued or started during pregnancy in a woman with pre‑existing type 2 diabetes mellitus or polycystic ovary syndrome (PCOS), and is it appropriate for gestational diabetes when diet and exercise fail, assuming adequate renal function (creatinine clearance ≥ 60 mL/min) and a maximum dose of 2,500 mg per day?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.